Market Place
Sourcing Support
Syncona announces sale of portfolio company to Novartis
18 Feb 2022 //
PHARMATIMES
Novartis Bolsters Retinal Gene Therapy Position with $1.5 Billion Acquisition
23 Dec 2021 //
BIOSPACE
Novartis buys UK`s Gyroscope for $1.5B to get gene therapy for eye disease
21 Dec 2021 //
REUTERS
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
09 Nov 2021 //
PHARMATIMES
Gyroscope spins the wheel again as it taps Sanofi for $60M
09 Nov 2021 //
PHARMAPHORUM
Eye-focused gene therapy startup gets $60M cash infusion from Sanofi
08 Nov 2021 //
BIOPHARMADIVE
AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more
08 Nov 2021 //
ENDPTS
Gyroscope Announces Presentation of Positive Interim Phase I/II Data GT005
30 Sep 2021 //
GYROSCOPETX
Gyros Protein Technologies and Cygnus Technologies Expand Collaboration
08 Jul 2021 //
BUSINESSWIRE
Gyroscope Therapeutics withdraws plans for IPO
10 Jun 2021 //
SEEKING ALPHA
Gyroscope Therapeutics Postpones Initial Public Offering
06 May 2021 //
BUSINESSWIRE
Gyroscope and Talaris set IPO terms
03 May 2021 //
ENDPTS
Gyroscope bags $148M for AMD gene therapy trials, mulls IPO
26 Mar 2021 //
FIERCEBIOTECH
Gyroscope Therapeutics Announces Additional Financing Plans
26 Mar 2021 //
BUSINESSWIRE
Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing
26 Mar 2021 //
BUSINESSWIRE
Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing
25 Mar 2021 //
BUSINESSWIRE
Gyroscope Announces Positive Interim Data from Phase I/II FOCUS Trial
12 Feb 2021 //
BUSINESSWIRE
Gyroscope Therapeutics Announces Appointments of Industry Veterans
02 Dec 2020 //
BUSINESSWIRE
Gyroscope Announces Appointments of Industry Veterans in Gene Therapy
01 Dec 2020 //
BUSINESSWIRE
Gyroscope Announces Appointments of Industry Veterans in Gene Therapy
01 Dec 2020 //
BUSINESSWIRE
Gyroscope Announces First Patient Dosed in Phase II HORIZON Trial, GT005
12 Nov 2020 //
BUSINESSWIRE
Gyroscope initiates phase III HORIZON trial of GT005 to treat dry age-related
12 Nov 2020 //
PHARMABIZ
Gyroscope Announces First Patient Dosed in PhII HORIZON, GT005
11 Nov 2020 //
BIOSPACE
Gyroscope Announces First Patient Received Investigational Gene Therapy GT005
27 Oct 2020 //
PRESS RELEASE
US FDA grants fast track status to Gyroscope’s GT005
22 Sep 2020 //
PHARMABIZ
Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005
21 Sep 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.